Kentucky Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kentucky Tech Times.

Press releases published on August 5, 2026

Aug. 5, 2026

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Indeterminate GlobeNewswire

Aug. 5, 2026

Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission

Indeterminate GlobeNewswire

Aug. 5, 2026

FingerMotion Announces Leadership Change

Indeterminate GlobeNewswire

Aug. 5, 2026

Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program

Indeterminate GlobeNewswire

Aug. 5, 2026

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Indeterminate GlobeNewswire

Aug. 5, 2026

Micware Co., Ltd. to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire

Aug. 5, 2026

ミックウェア、今後開催される2件の投資家向けコンファレンスに参加

Indeterminate GlobeNewswire

Aug. 5, 2026

Adneuris Therapeutics Grants Exclusive License to Maruishi Pharmaceutical to Advance Cebranopadol in Japan and South Korea

Indeterminate GlobeNewswire

Aug. 5, 2026

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

Indeterminate GlobeNewswire

Aug. 5, 2026

Quantum X-Labs Advances Quantum Computing for Nuclear Particle Transport prediction 

Indeterminate GlobeNewswire

Aug. 5, 2026

Military Demand to Anchor Global sUAS Market Growth as Commercial Drone Adoption Expands Across Key Verticals

Indeterminate GlobeNewswire

Aug. 5, 2026

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Indeterminate GlobeNewswire

Aug. 5, 2026

Autonomize AI Launches Fraud, Waste, and Abuse AI-native App in the ServiceNow Store

Indeterminate GlobeNewswire

Aug. 5, 2026

Talos Integrates with STS Digital to Bring Institutional Crypto Options and Spot Liquidity to its Provider Network

Indeterminate GlobeNewswire

Aug. 5, 2026

ImageneBio Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 5, 2026

Rocket Doctor AI joins the B2i Digital Featured Company Program and its Network of more than 1.7 million Retail and Institutional Market Participants

Indeterminate GlobeNewswire

Aug. 5, 2026

UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights

Indeterminate GlobeNewswire

Aug. 5, 2026

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Indeterminate GlobeNewswire

Aug. 5, 2026

One Stop Systems Reports Q2 2026 Results

Indeterminate GlobeNewswire

Aug. 5, 2026

Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

Indeterminate GlobeNewswire